XTNT · Xtant Medical Holdings Inc
United States · RS rating 12 · As of 2026-11-03
| Price | 0.28 USD |
|---|---|
| 1-day change | -0.7% |
| RS rating (overall / 1M / 3M / 12M) | 12 / 26 / 15 / 13 |
| Stage | Declining |
| Composite / Minervini / CANSLIM score | 11 / 7 / 2 |
| Industry group (rank) | Medical-Products (106) |
| EPS growth Q/Q | – |
| Sales growth Q/Q | -2.7% |
| Distance from 52-week high | +65.7% |
| Market cap (USD) | $71.4M |